necrosis factor-alpha in plasma. Oxidative stress was also alleviated after RBPH treatment by decreasing plasma malondialdehyde, reducing superoxide production and suppressing p47
Introduction
Metabolic syndrome (MetS) is recognized as a multiplex risk factor for cardiovascular disease (CVD). It is composed of abdominal obesity, atherogenic dyslipidemia, raised blood pressure, insulin resistance, proinflammatory and prothrombotic states [1] . Metabolic syndrome increases the risk of CVD, a disease which is estimated to cause half the global mortality attributable to non-communicable diseases [2] . The dramatic increase in patients with MetS during recent decades is most likely due to sedentary lifestyle and unhealthy diet [3] . The initiation of the symptoms of MetS is linked to high-carbohydrate and high-fat diet-induced oxidative stress [4] . Rats are commonly used as a model for human diseases, including metabolic syndrome, and it has Abstract Purpose Rice bran protein hydrolysates (RBPH) contain highly nutritional proteins and antioxidant compounds which show benefits against metabolic syndrome (MetS). Increased arterial stiffness and the components of MetS have been shown to be associated with an increased risk of cardiovascular disease. This study aimed to investigate whether RBPH could alleviate the metabolic disorders, arterial stiffening, vascular remodeling, and oxidative stress in rats fed a high-carbohydrate and high-fat (HCHF) diet. Methods Male Sprague-Dawley rats were fed either a standard chow and tap water or a HCHF diet and 15 % fructose solution for 16 weeks. HCHF rats were treated orally with RBPH (250 or 500 mg/kg/day) for the final 6 weeks of the experimental period. Results Rats fed with HCHF diet had hyperglycemia, insulin resistance, dyslipidemia, hypertension, increased aortic pulse wave velocity, aortic wall hypertrophy and vascular remodeling with increased MMP-2 and MMP-9 expression. RBPH supplementation significantly alleviated these alterations (P < 0.05). Moreover, RBPH reduced the levels of angiotensin-converting enzyme (ACE) and tumor 1 3 been demonstrated that rats fed on high-carbohydrate and high-fat (HCHF) diet exhibit the symptoms of MetS, such as dyslipidemia, impaired glucose tolerance, hypertension, enhanced proinflammatory markers, increased oxidative stress and decreased antioxidant defences [4] [5] [6] .
Oxidative stress together with chronic inflammation, induced by sugars and lipids, may initiate changes in cardiovascular function and structure such as endothelial dysfunction, cardiac dysfunction, cardiac fibrosis and vascular remodeling [7] . Inflammation is reported to down-regulate endothelial nitric oxide synthase (eNOS) expression and increase NADPH oxidase activity, which leads to endothelial dysfunction [4, 8, 9] and consequent vascular dysfunction [10] . A loss of vascular distensibility, increase in arterial wall stress and modifications in blood vessel composition may lead to further vascular remodeling and stiffening [11] [12] [13] . Hence, alleviation of vascular remodeling and reduction of conduit arterial stiffness is an important therapeutic target to lessen the cardiovascular risk factors related to MetS.
Numerous studies have shown that a high consumption of plant foods which contain high concentrations of antioxidants, such as whole grains, nuts, fruits and vegetables, will alleviate the metabolic disorders and reduce the risk of CVD [14] . Consumption of proteins has been demonstrated to modulate endogenous lipid profiles during dyslipidemia [15] . Rice bran, comprising about 10-15 % by weight of rough rice, is an inexpensive, underutilized major by-product of milling. It has high nutritional value and can be exploited in functional foods as rice bran protein. Defatted rice bran contains a high concentration of protein, which may be applied as a nutraceutical product [16] . Rice bran protein is considered a valuable plant protein with unique nutritional and hypoallergenic properties in comparison with proteins from other cereals and legumes. It is an important source of other nutrients such as peptides, dietary fibers and bioactive phytochemicals [17] . The recent production of water soluble rice bran protein hydrolysates (RBPH) provides advantages over other rice bran derivatives such as a high content of nutraceutical compounds and a reduced tendency to become rancid [18] [19] [20] [21] [22] . Our recent investigations have demonstrated that supplementation with RBPH in renovascular hypertensive rats can improve endothelial function and moderate hypertension through angiotensin-converting enzyme (ACE) inhibitory, vasodilatory and antioxidant activities [23] . Moreover, RBPH ameliorates cardiovascular risk factors by strongly reducing inflammation, dyslipidemia and insulin resistance [18, 21, 24, 25] . However, little is known about the effect of RBPH on the alterations of hemodynamics, arterial stiffness and vascular remodeling in MetS. Therefore, the aim of this study was to investigate whether RBPH could improve metabolic status, alleviate oxidative stress and restore hemodynamic status, arterial stiffness and vascular remodeling in a HCHF diet-induced rat model of MetS.
Materials and methods

Experimental animals and diets
All experimental procedures were approved by the Institutional Animal Ethics Committee of Khon Kaen University (AEKKU 19/2555). Male Sprague-Dawley rats weighing 220-250 g were obtained from the National Laboratory Animal Center, Mahidol University, Salaya (Nakornpathom, Thailand). All animals were housed at the Northeast Laboratory Animal Center (Khon Kaen University, Khon Kaen, Thailand) in a temperature-controlled room (23 ± 2 °C) with a 12-hour light/dark cycle.
Rats were randomly assigned to 5 groups, 16 animals each. Eight animals from each group were used for measurements of pulse wave velocity (PWV), hemodynamic status, oxidative stress markers and protein expression. The remaining eight were used for biochemical evaluations, histological and morphometric analysis and immunohistochemistry. The five groups were: control, control + RBPH500, HCHF, HCHF + RBPH250 and HCHF + RBPH500, where the numbers refer to the RBPH dose in mg/kg body weight/day. Control animals were fed with standard chow diet (Chareon Pokapan Co. Ltd., Bangkok, Thailand) with tap water as drinking water, and distilled water was administered orally as a vehicle for RBPH or RBPH 500 mg/kg/day. HCHF rats were fed with high-carbohydrate and high-fat diet with 15 % fructosesupplemented drinking water and given distilled water or RBPH solution 250 or 500 mg/kg/day, administered orally. The dose range of RBPH used in this study was based on our previous work [25] , which showed that it is sufficient to reduce the fasting blood glucose in insulin resistant animals.
The HCHF diet was prepared as previously described [5] . In brief, it consisted of 175 g fructose, 350 g condensed milk, 200 g pork tallow, 200 g powdered rat chow, 25 g of Hubble, Mendel and Wakeman salt mixture and 50 g water per kilogram of diet. The energy densities of the standard diet and the HCHF diet were 387 and 423 kcal/100 g, respectively. Rats in all groups were given free access to the specified diet and drinking water for 16 weeks. At week 10, RBPH were administered to rats in the two rice bran groups for the last 6 weeks of the experimental period.
Preparation of RBPH
Defatted jasmine (Hom Mali 105) rice bran obtained by the cold-pressed method was supplied by Community Organic Produces Enterprise, Lopburi, Thailand. RBPH were prepared as described previously [26] . In brief, defatted rice bran was suspended in distilled water at pH 11.0. The slurry was centrifuged at 5000g for 30 min, and the supernatant was adjusted to pH 4.5 for precipitation. The precipitate was suspended in distilled water at pH 7.0 and subjected to proteolysis with a commercial proteolytic enzyme, Protease G6 (Genencor International Inc., Palo Alto, CA, USA) at pH 8.0, 55 °C for 4 h. The enzyme was inactivated at 85 °C for 15 min. After centrifugation, protein hydrolysates were lyophilized using a freeze dryer. The RBPH powder was stored in air-tight containers and kept at −20 °C. The yield of crude RBPH was 8.8 % by weight from the defatted rice bran. The protein content, crude fat, moisture and total phenolic content were analyzed according to the AOAC standard protocol [27] . The composition of crude RBPH was: protein content, 23.51 %; crude fat, 16.32 %; moisture, 4.40 %; and total phenolic content: 20.38 mg of Gallic acid/g powder.
Indirect measurement of the blood pressure in conscious rats
Systolic blood pressure (SBP) was monitored in conscious rats with an inflatable tail-cuff connected to a Rat Tail-Cuff Blood Pressure System (IITC/Life Science Instrument model 299 and model 179 amplifier; Woodland Hills, CA, USA) as previously described [28] . SBP of each rat was obtained from an average of 3 readings. SBP was monitored every 2 weeks throughout the experimental period.
Aortic pulse wave velocity and hemodynamic measurements
Sixteen weeks after the start of the experiment, rats were anesthetized with an intraperitoneal injection of pentobarbital sodium (60 mg/kg) and placed on a heat pad to maintain body temperature. A tracheotomy was performed. The aortic PWV was determined in vivo as previously described [29, 30] . Briefly, two polyethylene catheters (0.97 mm outer diameter/0.58 mm inner diameter, Warner Instruments, Harvard Apparatus, Holliston, MA, USA) were passed into the aorta. One was advanced into the aortic arch via the left carotid artery, and the other was advanced into the abdominal aorta just proximal to the iliac bifurcation via the left femoral artery. Each catheter was connected to a pressure transducer (Model TSD104A) interfaced with a general-purpose transducer amplifier (DA100C, BIOPAC Systems Inc., CA, USA). The aortic pressure pulse wave forms were captured continuously using the AcqKnowledge data acquisition of the BIOPAC systems at a sampling rate of 1000 Hz and displayed in real time. The aortic pressure waves at both sites and heart rate (HR) were recorded for 10-15 min, during which time the rats were hemodynamically stable. Subsequently, hindlimb blood flow (HBF) was measured as previously described [12] by placing an electromagnetic flow probe around the abdominal aorta, accessed through a laparotomy, just below the branches of the renal arteries. The electromagnetic flow probe was connected to an electromagnetic flowmeter (Carolina Medical Electronics, NC, USA). Hindlimb vascular resistance (HVR) was calculated from the mean arterial pressure (MAP) divided by HBF. After the hemodynamic measurements were completed, the animals were euthanized with pentobarbital sodium (120 mg/kg). A blood sample was withdrawn from the femoral artery and centrifuged at 3500g for 15 min at 4 °C to separate the plasma, which was then stored at −20 °C for biochemical determinations.
PWV was calculated by dividing the propagation distance (L) by the transit time (t). The distance between the two cannula tips was measured in situ by placing a damp silk thread along the aorta and marking it at the tips of the two pressure catheters. The length of the silk thread to the nearest 0.05 mm was measured using Vernier calipers. The transit time for the pulse wave as it travelled from the aortic arch to the iliac bifurcation was obtained from the average foot-to-foot delay between the simultaneously recorded pressure waves at each site for 10 min by using custom written software (Pulse monitor & display V3.1), which measured the time delay between the start of the rising edge of corresponding cardiac cycles recorded at each end of the aorta from their smoothed second derivatives. Thereafter, the left and right carotid arteries and the aorta were removed from the rat and used for measurement of the superoxide anion (O 2 ·− ) production and the Western blot analysis of endothelial nitric oxide synthase (eNOS) and p47 phox nicotinamide adenine dinucleotide phosphate (NADPH) oxidase expression. In a separate set of experiments, after euthanization, the thoracic aortas obtained from 8 rats in each group were fixed in 4 % phosphatebuffered formaldehyde for structural investigations.
Blood biochemical assays
Fasting blood glucose (FBG) and serum insulin level of fasting blood were measured, and insulin resistance was evaluated according to the homeostasis model assessment (HOMA) method described by Matthews et al. [31] . The HOMA-IR index was calculated as: (Fasting insulin (µU/mL) × Fasting glucose (mmol/L))/39.5, where 39.5 is a normalizing factor derived from the basal concentrations of insulin and blood glucose obtained from normal rats. In this study, the median value of fasting insulin of normal rats was 8 μU/mL, whereas the median value of fasting blood glucose was 4.94 mmol/L, thereby, 8 × 4.94 = 39.5. Blood glucose was examined using a glucometer (ACCU-CHEK ® , Roche Diagnostics GmbH, Mannheim, Germany). Serum insulin level was measured using a Rat Insulin ELISA Kit (Millipore Corporation, Billerica, MA, USA). Plasma triglyceride (TG) and HDL cholesterol (HDL-C) levels were measured using enzymatic and colorimetric methods (Roche Diagnostics, Bangkok, Thailand). The plasma concentration of tumor necrosis factor-alpha (TNF-α) was determined by an ELISA kit (Bioscience, Inc., San Diego, CA, USA). Plasma ACE activity was measured by using the o-phthalaldehyde (OPA)-chromogenic reaction as previously described [24] .
Assessment of oxidative stress
Vascular superoxide (O 2 ·− ) production was performed in carotid arteries by using the lucigenin-enhanced chemiluminescence technique as previously reported [32] . Plasma malondialdehyde (MDA) was assessed by measuring thiobarbituric acid reactive substances following a previously described method [12] . The plasma nitrate/nitrite level, the end product of NO metabolism, was quantified by an enzymatic conversion method with the Griess reaction as previous described [12] .
Western blot analysis
Western blotting was performed on the aortas from each experimental group to detect eNOS and p47 phox as previously described [12, 23] . The intensities of specific eNOS, p47 phox and β-actin bands were visualized and captured by ImageQuant™ 400 (GE Healthcare Life science, Piscataway, NJ, USA). The relative expression levels of eNOS, p47 phox protein were normalized to β-actin expression from the same sample, and values were expressed as percentages of those from the aorta of normal controls.
Morphometric analysis of the vascular wall
Rings of the fixed thoracic aortas, 5 mm in length, were embedded in paraffin and sections cut at 5 µm thickness. Consecutive sections were stained with hematoxylin and eosin (H&E) to visualize VSMC nuclei, Picrosirius Red to stain collagen and Miller's stain to identify elastin. From these sections, the number of VSMCs and the area fraction of collagen and elastin in the aortic media were determined. These structural analyses were evaluated by image analysis software (Image-Pro Plus, Media Cybernetics, MD, USA) as previously described [28] . The medial cross-sectional area (CSA), aortic wall thickness, media to lumen ratio (M/L) and lumen area were also calculated [28, 33] .
Immunohistochemistry
The amount of smooth muscle α-actin (SMA) and the localization of MMP-2 and MMP-9 in the thoracic aorta were assessed from the de-waxed aortic sections by using specific antibodies as previously described [24] . The area fraction of immunohistochemically stained SMA, MMP-2 or MMP-9 was quantified by the Image-Pro Plus Program. The immunoreactivity assessment for both MMP-2 and MMP-9 was quantified by grading the immunohistochemical staining intensity on a scale of 1 to 3; 1 for light brown to yellow, 2 for moderate brown and 3 for dark brown [33] . The values were expressed in arbitrary units, obtained by multiplying the percentage of area fraction and the intensity score.
Statistical analysis
All values were expressed as mean ± standard error of the mean (SEM). Statistically significant difference among groups was sought using one-way analysis of variance (ANOVA) followed by the Student-Newman-Keuls post hoc test. The criterion for statistical significance was set at P < 0.05.
Results
Effect of RBPH on systolic blood pressure and metabolic variables
A MetS model was achieved by feeding male Sprague-Dawley rats with a HCHF diet for 16 weeks. Elevation of blood pressure is one of the characteristics of MetS. Figure 1 shows Fig. 1 Effect of RBPH on systolic blood pressure during the experimental period measured by tail-cuff plethysmography in all experimental groups. Each point represents the mean ± SEM, n = 8/group. *P < 0.05 versus Control, # P < 0.05 versus HCHF group, † P < 0.05 versus HCHF with RBPH 250 mg/kg. HCHF high carbohydrate, high fat; RBPH rice bran protein hydrolysates the time-course of the changes in SBP during the experimental period. The SBP of HCHF-diet-fed rats was significantly increased when compared to standard chow-fed rats (P < 0.05; Fig. 1 ). RBPH significantly reduced the blood pressure of HCHF-diet-fed rats when compared to the HCHF untreated group (P < 0.05; Fig. 1 ). The reduction in SBP was more pronounced in HCHF-diet-fed rats treated with RBPH at high concentration (500 mg/kg). On the other, RBPH did not change the SBP of the control rats fed with normal diet, indicating that RBPH do not have a hypotensive effect (Fig. 1) .
Rats fed a HCHF diet gained body weight at a similar rate to that of control rats fed on a standard chow diet ( Table 1 ). The data indicate that HCHF diet had no effect on the growth rate. It is found that the energy intake of HCHF rats was higher than that of control rats (P < 0.05; Table 1 ). FBG, serum insulin, HOMA-IR scores and plasma triglyceride concentrations were elevated in HCHFfed rats when compared to normal diet-fed rats (P < 0.05; Table 1 ). Moreover, plasma HDL-C level decreased in the HCHF group (P < 0.05; Table 1 ). Interestingly, the severity of all of these metabolic disorders was significantly decreased after treatment with RBPH, especially at high concentration (P < 0.05; Table 1 ). There were no differences in the metabolic parameters in control rats treated or those not treated with RBPH.
Effect of RBPH on hemodynamics and PWV
We found that the HCHF diet increased arterial blood pressure (systolic, diastolic, mean arterial pressure and pulse pressure), decreased HBF and increased HVR when compared with the control groups (P < 0.05; Table 2 ). Moreover, 6.32 ± 0.31 c a significantly increased HR was found in HCHF-fed rats. These hemodynamic alterations were significantly improved after RBPH treatment in a dose-dependent way (P < 0.05; Table 2 ). RBPH did not change the measured hemodynamic variables in the control rats (Table 2 ). In HCHF-fed rats, PWV increased by 40 % when compared to control animals (P < 0.05; Table 2 ). A significant decrease in PWV was found after RBPH treatment. A reduction in PWV of the HCHF + RBPH500 group was associated with a decrease in pulse pressure (Table 2) . These results indicate that RBPH increase aortic compliance. Treatment with RBPH alone had no effect on PWV when compared to the values in the control diet group ( Table 2) .
Effect of RBPH on inflammation, ACE activity and oxidative stress
The levels of TNF-α and ACE in plasma were markedly increased in HCHF-fed rats, and we observed that RBPH effectively decreased these levels as shown in Table 3 . These results suggest that RBPH reduced inflammation and decreased angiotensin II production in HCHF-diet-fed rats. Again, RBPH did not alter plasma TNF-α and ACE activity in normal diet-fed rats (Table 3) . Increased vascular O 2 ·− production and elevated plasma MDA concentration were found in HCHF-fed rats (P < 0.05; Table 3 ), suggesting increased oxidative stress phox NADPH oxidase subunit in the aortas of HCHF rats (P < 0.05; Fig. 2a ) confirms increased ROS production after receiving the HCHF diet. A reduction in plasma nitrate/nitrite level and eNOS protein expression in aortic tissues was also found in HCHF-fed rats (P < 0.05; Table 3 and Fig. 2b) . These results indicate a depletion of NO bioavailability in MetS animals. Interestingly, RBPH, especially the higher concentration, significantly reduced oxidative stress and increased NO bioactivity by reducing vascular O 2 ·− and plasma MDA levels and increasing plasma nitrate/nitrite concentration (P < 0.05; Table 3 ). Moreover, a down-regulation of p47 phox and an up-regulation of eNOS protein expressions were also found in HCHF rats treated with RBPH (Fig. 2a, b) .
Effect of RBPH on vascular remodeling
To determine whether the administration of HCHF diet alters the structure of conduit arteries, we assessed vascular remodeling in thoracic aortas by quantifying aortic wall thickness, aortic medial CSA, M/L ratio, VSMC number and collagen and elastin contents. The aorta of HCHFdiet-fed rats was remodeled by increasing wall thickness, medial CSA and M/L ratio (Fig. 3a-c) , whereas no difference in the lumen areas was found (data not shown). Moreover, a significant increase in the amounts of SMA and the number of VSMCs per medial CSA were found in the aortic wall of HCHF-diet-fed rats (Fig. 4a, b) . Importantly, treatment with RBPH, especially a high dose, significantly SMA smooth muscle actin; HCHF high carbohydrate, high fat; RBPH rice bran protein hydrolysates; CSA cross-sectional area; VSMCs vascular smooth muscle cells attenuated these changes in HCHF-fed rats. In addition, the Picrosirius Red and Miller's stained sections of HCHFfed rats showed a significant increase in collagen content with a trend toward decreased elastin content in the aortic wall (Fig. 4c, d ). Treatment with RBPH significantly decreased collagen content in HCHF-fed rats (Fig. 4c) .
We also evaluated the two markers of vascular remodeling, MMP-2 and MMP-9 by using immunohistochemistry. Representative immunohistochemistry images showed increased MMP-2 and MMP-9 in the aortas of HCHFfed rats compared with the normal control diet-fed rats (Fig. 5a, b) . These increases were significantly attenuated by treatment with RBPH, especially at the high dose. There were no significant differences in the MMP-2 and MMP-9 levels between the normal control diet-fed rats and normal control diet-fed rats treatment with RBPH (Fig. 5a, b) .
Discussion
Metabolic syndrome is a major health problem worldwide that requires better preventive and therapeutic strategies [34] . Apart from pharmacological treatment for patients with MetS, nutrients rich in antioxidants could be used to slow the progression of the disease, especially its cardiovascular complications, and to limit the side effects of drug intake [35] . RBPH derived from defatted Hom Mali rice bran containing a high concentration of phenolic compounds were used in this study. We found that the RBPH improve the symptoms of MetS by decreasing blood pressure and reducing dyslipidemia and insulin resistance in HCHF diet-induced MetS in rats. Moreover, RBPH mitigate oxidative stress, hemodynamic disturbance, aortic stiffness and vascular remodeling of HCHF-diet-fed rats.
A diet rich in carbohydrate and fat in this study was associated with increased blood pressure, blood glucose, insulin resistance, hypertriglyceridemia and low HDL-C in male Sprague-Dawley rats. All of these pathologic features mimic the signs of metabolic syndrome found in humans [34] . The metabolic disorders seen in HCHF-dietfed rats were alleviated by RBPH treatment. These findings are in agreement with previous studies in HCHF-diet-fed rats [25] , obese Zucker rats [19] , stroke-prone spontaneously hypertensive rats [36] and type 2 diabetic mice [37] . A recent study by our group demonstrated that RBPH decreased the levels of proinflammatory cytokines (Il-6, Nos-2 and Mcp-1) and suppressed the expression of lipogenic genes (Srebf1and Fasn) [25] , suggesting that RBPH mitigate insulin resistance and dyslipidemia. Moreover, we found that increased insulin sensitivity in HCHF-diet-fed rats treated with RBPH was associated with a reduction in plasma TNF-α, revealing the anti-inflammatory property of RBPH. All of these results support the beneficial effect of RBPH against metabolic changes induced by a HCHF diet. Endothelial dysfunction is associated with the pathogenesis of cardiovascular risk factors such as hypertension, dyslipidemia, diabetes, smoking and obesity [38] . In agreement with other studies [39, 40] , a blunted endothelium-dependent vasodilatory response to acetylcholine, an indicator of endothelial dysfunction was also found in HCHF-diet-fed rats [5] . Decreased plasma nitrate/nitrite level and down-regulated eNOS protein expression in the aortas in this study has confirmed the impairment of endothelial function. It has been suggested that endothelial dysfunction may contribute to more generalized vascular dysfunction [41] . In this study, vascular dysfunction in the form of hemodynamic disturbances, as evidenced by increased arterial blood pressure (SBP, SDP, PP and MAP), decreased peripheral blood flow (i.e., decreased HBF) and increased peripheral vascular resistance (i.e., increased HVR), was found in HCHF-diet-fed rats. Moreover, aortic stiffness expressed as increased aortic PWV, which is a strong predictor of cardiovascular events [42] , was also found in the HCHF-diet-fed rats. PWV is increased in rats treated with NO inhibitor, L-NAME [29] , which suggests that the endogenous NO system plays a role in the maintenance of vascular compliance. Moreover, Kameyama et al. [43] demonstrated that increased PWV is associated with vascular structural changes of the aortas in L-NAMEtreated rats. Similarly, we found endothelial dysfunction, aortic stiffness and vascular structural changes in a rat model of MetS induced by HCHF diet. The observed increase in wall thickness, medial CSA, M/L ratio, smooth muscle cell proliferation and collagen deposition suggests structural changes with hypertrophic remodeling of the aortas in HCHF-diet-fed rats. Increase in collagen without significant changes in the elastin contents in HCHF-fed rats is similar to those found in rats fed with a high-fat diet [44] . In this study, RBPH markedly reduced aortic medial wall thickness and attenuates the progression of vascular remodeling in MetS rats. These novel findings reveal the direct beneficial effects of RBPH in improving vascular structural changes and remodeling in MetS rats.
Vascular remodeling is a multifactorial process that includes leukocyte activation and increased production of reactive oxygen species (ROS), which are associated with metabolic syndrome [45] . Matrix metalloproteinases (MMPs) are calcium-dependent zinc-containing endopeptidases, which play an important role in degrading extracellular matrix (ECM) and promoting VSMC migration and proliferation [10, 46] . MMP-2 and MMP-9 [10] , the most prominent in vascular remodeling, are synthesized by several vascular cell types, including endothelial cells and associated pericytes and podocytes, vascular smooth muscle cells, fibroblasts and myofibroblasts, monocytederived macrophages and local tissue macrophages [47] . Increased MMP-2 and MMP-9 expressions, which reflect abnormalities of ECM metabolism, are found in the aortas of HCHF diet-induced MetS rats. These results are in agreement with previous studies in rats and humans with metabolic syndrome [8, [48] [49] [50] [51] . A previous study revealed that elevated MMP-9 concentration is positively correlated with increased carotid-femoral pulse wave velocity in hypertensive patients [52] . Thus, MMP-9 is associated with changes in arterial stiffness and with development and progression of hypertension. Similarly, in the HCHFtreated rats in this study, we observed that increased aortic MMP-9 expression was associated with increased pulse pressure and aortic PWV. The renin-angiotensin II system and MMP-9 are considered to be closely involved in the development of MetS and its complications [53] . It has been demonstrated that ACE inhibitors and angiotensin II receptor blockers decrease aortic stiffness [54] and prevent collagen accumulation in the aorta [55] . In agreement with previous reports, we found that RBPH significantly reduced plasma ACE activity and aortic collagen content in HCHFdiet-fed rats, suggesting that one possible mechanism to explain the protective effect of RBPH is its ACE-inhibitory activity.
The metabolic syndrome constitutes a milieu conducive to tissue redox stress [47] . In accord with a previous study [5] , increased O 2 ·− production through up-regulation of the p47 phox NADPH oxidase subunit enhances ROS generation in the vasculature which, in turn, contributes to reduced NO bioavailability, thereby promoting endothelial dysfunction, increased vascular resistance and hypertension. Elevated oxidative stress [28, 56] and increased inflammatory cytokine secretion, i.e., TNF-α [8, 57] , are associated with an increase in matrix MMP activity. It has been found that treatment with lumiracoxib, a cyclooxygenase-2 inhibitor, reduces MMP-2 and MMP-9 activities and expressions in fructose-fed hypertensive rats [8] . Moreover, antioxidant compounds which have anti-inflammatory activity could also attenuate vascular remodeling in hypertensive rats [23, 33] . Therefore, data from previous observations provide a rationale for antioxidant therapy to moderate vascular alterations. In this study, treatment with RBPH, an antioxidant containing a high concentration of phenolic compounds is able to increase NO production via up-regulation of eNOS protein expression; to decrease vascular O 2 ·− through a down-regulation of p47phox NADPH oxidase subunit and to reduce plasma MDA, TNF-α and ACE activity in HCHFdiet-fed rats. Collectively, the results of this study suggest that RBPH possess not only antioxidant activity, but also anti-inflammatory and anti-ACE inhibitory properties.
In conclusion, the present study demonstrates the protective effect of RBPH derived from Thai rice bran in a rat model of metabolic syndrome induced by an HCHF diet. The beneficial effects of RBPH include amelioration of metabolic changes, reduction in aortic stiffening, improvement of hemodynamic status, reduced vascular dysfunction and remodeling and alleviation of inflammation and oxidative stress. Overall, the findings support the potential use of RBPH as food supplements to protect or delay the progression of metabolic syndrome and its associated complications in humans. However, measurements of the dose-response effects of these supplements are required before recommending their use as a dietary supplement.
